Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bizarre appearance of chronic cutaneous lupus erythematosus of face mimicking factitial dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

Same author

Parallel ridge dermoscopic pattern in plantar atypical Spitz nevus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

Same author

Assessment of Prognostic Factors in 102 Patients with Myelodysplastic Syndrome-Osteoblasts are Related to Survival.

Hematology (Amsterdam, Netherlands)·2016

Same author

Aberrant Ikaros, Aiolos, and Helios expression in Hodgkin and non-Hodgkin lymphoma.

Blood·2008

Same author

Application of the FICTION technique for the simultaneous detection of immunophenotype and chromosomal abnormalities in routinely fixed, paraffin wax embedded bone marrow trephines.

Journal of clinical pathology·2005

Same author

Molecular insight into the diagnosis of lymphoma.

International journal of molecular medicine·2003

Search research articles

Related Experiment Videos

[Castleman's disease].

M Bradamante¹, M Dominis

¹Odjel za patologiju i citologiju Klinicke bolnice Merkur u Zagrebu.

Lijecnicki Vjesnik

|August 8, 2009

Summary

This summary is machine-generated.

Castleman's disease, a lymphoproliferative disorder, presents diagnostic challenges. This study highlights potential malignant transformations in both plasma-cellular and hyaline-vascular subtypes, impacting patient prognosis.

Related Experiment Videos

Area of Science:

Hematology
Oncology
Pathology

Background:

Castleman's disease is a rare lymphoproliferative disorder with unknown etiology and uncertain prognosis.
Histological classification includes hyaline-vascular and plasma-cellular subtypes.
The potential for malignant transformation in Castleman's disease necessitates further investigation.

Observation:

Five patients diagnosed with Castleman's disease were analyzed.
Lymph nodes and spleen were examined using standard histological procedures.
Three patients were diagnosed with the plasma-cellular type, and two with the hyaline-vascular type.

Findings:

Of the three patients with plasma-cellular Castleman's disease, two developed malignant lymphoma.
One of the two patients with hyaline-vascular Castleman's disease developed a follicular dendritic cell tumor.
These findings suggest a higher risk of malignant transformation than previously recognized for both subtypes.

Implications:

The study indicates that both hyaline-vascular and plasma-cellular Castleman's disease carry risks of malignant transformation.
This underscores the importance of long-term monitoring for patients diagnosed with Castleman's disease.
Further research into the underlying mechanisms driving these transformations is crucial for improved patient outcomes.